Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg
Status:
Completed
Trial end date:
2017-08-09
Target enrollment:
Participant gender:
Summary
A randomized, open-label, multiple dosing, three treatment, three period, two sequence
clinical trial to investigate the pharmacokinetic/pharmacodynamic drug-drug interaction of
evogliptin 5 mg and glimepiride 4 mg after oral administration in healthy male subjects